Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of PAREXEL International Corporation (NASDAQ: PRXL) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of PAREXEL International Corporation (NASDAQ: PRXL)  concerning whether a series of statements by PAREXEL International Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On August 30, 2016, PAREXEL revealed that it was delaying the filing of its 2016 Form 10-K after it received a report "of an incident of misappropriation of corporate funds by an employee in one of the Company's international operations."

On this news, NASDAQ: PRXL dropped during intraday trading on August 31, 2016.

Based in Waltham, Massachusetts, and founded in 1983 PAREXEL International Corporation provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries.

If you purchased shares of PAREXEL International Corporation (NASDAQ: PRXL) on or before August 30, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185